Perrigo (NYSE:PRGO) announces a quarterly dividend of $0.21



Perrigo (NYSE:PRGO) to go ex-dividend.
On 4/26/2019 Perrigo ( NYSE:PRGO ) announced that it will be issuing a quarterly dividend in the amount of $0.21 down from $0.21 making the yield 1.68%.


Perrigo (NYSE:PRGO) Ex- dividend date

Perrigo (NYSE:PRGO) is set to go ex-dividend on and will be payable on 6/18/2019


Dividend History for Perrigo (NYSE:PRGO)
The next payable dividend for Perrigo is scheduled for 6/18/2019. There is an annual dividend of $$0.76 with a yield of 1.50% The company’s dividend has increased by 15.00% on a 3 Year Average

Recent Dividend History for Perrigo (NYSE:PRGO)

  • On 1/31/2013 Perrigo announced a quarterly dividend of $0.09.
  • On 5/2/2013 Perrigo announced a quarterly dividend of $0.09.
  • On 8/14/2013 Perrigo announced a quarterly dividend of $0.09.
  • On 11/6/2013 Perrigo announced a quarterly dividend of $0.09.
  • On 1/29/2014 Perrigo announced a quarterly dividend of $0.1050.
  • On 4/28/2014 Perrigo announced a quarterly dividend of $0.1050.
Story continues below



About Company
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, minerals and dietary supplements, feminine hygiene, diabetes care, scar management, and anti-parasite categories under the Good Sense, Sergeant's, Sentry, Zephrex D, PetArmor, and ScarAway brand names. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force. It operates in Europe, Australia, Israel, Mexico, the United States, Canada, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Recent Insider Trading for Perrigo (NYSE:PRGO)

  • On 11/12/2018 Geoffrey M Parker, Director, bought 3,000 with an average share price of $65.35 per share and the total transaction amounting to $196,050.00.
  • On 11/9/2018 Murray S Kessler, CEO, bought 15,683 with an average share price of $63.79 per share and the total transaction amounting to $1,000,418.57.
  • On 11/9/2018 Svend Andersen, EVP, bought 3,900 with an average share price of $63.01 per share and the total transaction amounting to $245,739.00.
  • On 11/9/2018 Todd W Kingma, VP, bought 3,200 with an average share price of $63.99 per share and the total transaction amounting to $204,768.00.
  • On 8/14/2018 Svend Andersen, EVP, bought 7,200 with an average share price of $69.43 per share and the total transaction amounting to $499,896.00.
  • On 5/17/2018 Jeffrey C Smith, Director, bought 50,000 with an average share price of $75.89 per share and the total transaction amounting to $3,794,500.00.



Recent Analyst Rating for Perrigo (NYSE:PRGO)

  • On 4/4/2019 SunTrust Banks, Lower Price Target, to Hold with a price target of $46.00
  • On 3/26/2019 Morgan Stanley, Lower Price Target, fromEqual Weight to Equal Weight with a price target of $67.00 to $54.00
  • On 2/28/2019 Royal Bank of Canada, Set Price Target, to Hold with a price target of $48.00
  • On 2/28/2019 Wells Fargo & Co, Set Price Target, to Hold with a price target of $47.00
  • On 12/24/2018 Leerink Swann, Lower Price Target, with a price target of $70.00 to $56.00
  • On 12/20/2018 Cantor Fitzgerald, Set Price Target, to Buy PRGO with a price target of $107.00



Recent Trading for Perrigo (NYSE:PRGO)
Shares of Perrigo closed the previous trading session at with shares trading hands.

An ad to help with our costs